RANI · Rani Therapeutics Holdings, Inc. · Documents

$0.58 +0.02 (+4.16%) Play latest call Q4 2025 earnings call transcript

Market Cap

$80.74M

139.40M

Volume · Nov 4 195.74K Avg daily vol (3M) 593.77K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022

Mar 29

Current report 8-K

Financial results

Mar 23

Current report 8-K Events of Mar 21

Entered into a material agreement

Feb 23

Current report 8-K

Financial results, Regulation FD disclosure

Jan 5

Current report 8-K Events of Jan 2

Director or officer change, or executive pay

2021

Nov 16

Current report 8-K Events of Nov 15

Financial results

Nov 16

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $0 Net loss $3.14M

Nov 16

Late filing notice NT 10-Q

Late filing notice

Nov 12

Current report 8-K Events of Nov 10

Director or officer change, or executive pay

Sep 29

Current report 8-K

Regulation FD disclosure

Sep 13

Current report 8-K

Financial results

Sep 13

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $1.96M ▲ 3168.3% Net loss $5.49M

Jul 26

Registration statement S-1/A

Registration statement

Jul 16

Registration statement S-1/A

Registration statement

Jul 9

Registration statement S-1

Registration statement

Showing 101–114 of 114 documents

Key facts CIK 1856725 CUSIP 753018100 13F (30d) 12 filings 12 filers Visit website Investor relations